Navigation Links
Gene Mutations Linked to Thyroid Cancer Risk: Study

FRIDAY, Dec. 30 (HealthDay News) -- Researchers have identified three gene abnormalities that appear to raise the likelihood for developing the thyroid cancer, with one in particular -- the PTEN gene -- implicated in children's risk for the disease.

Dr. Charis Eng, founding director of the Genomic Medicine Institute of Cleveland Clinic's Lerner Research Institute, said in a news release that her team's "investigation into the genetics behind thyroid disease raises important details relevant to diagnosis and treatment. We hope to promote the earliest diagnosis and most targeted treatment possible."

The researchers unearthed the gene-cancer risk link by examining and tracking roughly 3,000 patients, many of whom had already been diagnosed with a different disease called Cowden syndrome.

The study, published in the Dec 1. issue of the Journal of Clinical Endocrinology & Metabolism, focused on mutations in three genes: PTEN, SDH and KLLN. Because all work on distinct cell pathways, potential treatments to reduce cancer risk would have to target each gene individually.

Thyroid cancer has experienced the largest increase among both men and women of all cancers, according to the Cleveland Clinic release.

PTEN is a tumor-suppressor gene that, when healthy, aids in cell growth and division. Inherited PTEN mutations, however, impede the gene's normal function while spurring the growth of tumors. These abnormalities are known to be present in about 80 percent of patients with Cowden syndrome, who are considered at risk for developing breast and thyroid cancer.

The investigators concluded that mutations in the PTEN gene were indeed associated with a rise in thyroid cancer risk, with some early indications that mutations in the SDH and KLLN genes might also be implicated.

Children under the age of 18, however, seem to face a unique cancer risk dynamic: While PTEN mutations were seen to elevate their risk for thyroid cancer, SDH and KLLN abnormalities did not.

PTEN testing is already a staple in the world of genetic screening, the release noted.

More information

For more on thyroid cancer, visit the U.S. National Library of Medicine.

-- Alan Mozes

SOURCE: Journal of Clinical Endocrinology & Metabolism, news release, Dec. 23, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Massive DNA search uncovers new mutations driving blood cancer
2. Panel of melanoma mutations opens door to new treatment possibilities
3. Linking of mutations in 12 genes to ovarian cancer may lead to more effective prevention
4. Newly Found Gene Mutations May Aid Heart Treatments
5. Women With BRCA Mutations Get Cancer Diagnosis Earlier Than Before
6. Women who inherit BRCA gene mutations develop cancer earlier than their ancestors
7. Gene Mutations Identified in Uterine Fibroids
8. ADHD, Autism May Sometimes Share Gene Mutations
9. Elusive gene mutations found for malignant brain tumor
10. Scientists identify order of mutations that lead to cancer
11. Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment
Post Your Comments:
Related Image:
Gene Mutations Linked to Thyroid Cancer Risk: Study
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... will provide scholarships for people struggling with eating disorders as a result of ... the second annual event, held at Fox Run Golf Club in Eureka, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development and ... of its current state of the art research, development and manufacturing facility outside ... its manufacturing capacity as well as to support its clients’ growing research and ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Complex (TSC), as well as raising public awareness of the disorder while helping ... a third donation of $35,000 to bolster progress at the Tuberous Sclerosis Complex ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... treatment, is offering lower prices in an early celebration of the early holiday ... promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted ... to many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ ... of time the doctor uses other traditional cutting tools, such as the scalpel and ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Allergan plc ... an agreement with the New York State ... 2 of the Sherman Act, and other statutes with the ... in February 2014, to cease marketing and selling the now ... of settlement, Allergan admits no liability, has released its counterclaims ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology: